CSA Medical secures funding to advance cryospraytherapy platforms for esophageal disease and COPD

Image: CSA Medical has received $23m to advance cryospraytherapy platform for esophageal disease and COPD. Photo: courtesy of yodiyim / FreeDigitalPhotos.net.